I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 19 studies | 26% ± 7% | |
| conventional dendritic cell | 14 studies | 25% ± 8% | |
| dendritic cell | 10 studies | 31% ± 18% | |
| plasmacytoid dendritic cell | 10 studies | 30% ± 7% | |
| microglial cell | 10 studies | 37% ± 14% | |
| type I pneumocyte | 9 studies | 34% ± 12% | |
| classical monocyte | 9 studies | 24% ± 8% | |
| monocyte | 8 studies | 20% ± 5% | |
| myeloid cell | 8 studies | 23% ± 8% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 19% ± 2% | |
| mononuclear phagocyte | 4 studies | 32% ± 19% | |
| non-classical monocyte | 4 studies | 20% ± 5% | |
| leukocyte | 4 studies | 26% ± 11% | |
| natural killer cell | 4 studies | 18% ± 2% | |
| enteroendocrine cell | 4 studies | 39% ± 20% | |
| goblet cell | 4 studies | 19% ± 2% | |
| pericyte | 3 studies | 54% ± 9% | |
| epithelial cell | 3 studies | 21% ± 1% | |
| intestinal crypt stem cell | 3 studies | 20% ± 5% |
